Syk activators and inhibitors in neurodegenerative diseases
AssigneeUniversity of Virginia Patent Foundation
InventorsJohn R. Lukens, Hannah Elzabeth Ennerfelt, Elizabeth Frost
Life of this patent
Estimating the term…
Abstract
Provided herein are methods to treat neurodegenerative disease.
Claims19
A method to treat or prevent Aβ-driven neurodegeneration or a demyelinating disease comprising administering an activator of SYK to a subject in need thereof.
(canceled)
(canceled)
(canceled)
(canceled)
A method to generate an increase in spatial learning and/or memory in Aβ-driven neurodegeneration or a demyelinating disease comprising administering an activator of SYK to a subject in need thereof.
(canceled)
A method to treat or prevent a tauopathy comprising administering an inhibitor of SYK to a subject in need thereof.
Dependencies are inferred from the claim text.